Central Ohio Pilmonary Disease - OH Franklin, Columbus 43222

Central Ohio Pilmonary Disease entered the industry of Physicians Offices in 1977 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6211110, which describes it as a Physicians Offices. For further clarification, the SIC classifies this business under the code 8011 and described it as a Physicians Offices. The business provides service to the B2C market.

To acquire more information, please contact Sherri Whalen, Office Manager by calling (614) 464-0788 during business hours. You can also write to the business’ Single Location at 745 West State St # 510, Columbus, Ohio OH 43222. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Central Ohio Pilmonary Disease
Representative: Sherri Whalen, Office Manager
Place of Business: 745 West State St # 510, Columbus, OH 43222
Contact Number: (614) 464-0788
Type of Service: Physicians Offices
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1977
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Central Ohio Pilmonary Disease is a company operating from Franklin, Ohio providing professional Physicians Offices and relevant B2C variables. It was founded in 1977 and registered with the SIC code 8011 as Physicians Offices, and with the NAICS code 6211110 as Physicians Offices.

With a current employee count of 1 to 4, Central Ohio Pilmonary Disease has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Sherri Whalen, Office Manager at (614) 464-0788 for related queries, or to locate its Single Location using the coordinates 39.95778,-83.02038.

The Single Location can also be found at the street address 745 West State St # 510 in Columbus, Ohio 43222 and can be engaged online through the company website at , the company Twitter , and Facebook page .